The Bulletin
Times Advertising


.

HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals to Showcase Ongoing Parkinson's Disease Program at the 7th Annual Sachs Associates Neuroscience Innovation Forum

  • Written by PR Newswire
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals to Showcase Ongoing Parkinson's Disease Program at the 7th Annual Sachs Associates Neuroscience Innovation Forum

ROCKVILLE, Md., Dec. 20, 2023 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS), Daewoong Pharmaceutical (KRX: 069620.KS), and NurrOn Pharmaceuticals announced their participation in the 7th Annual Sachs Associates Neuroscience Innovation Forum. The event is scheduled to take place on January 7th, 2024, at the historic Marines' Memorial Club in San...

The Bulletin Magazine

THE BENEFITS OF A BUILDING AND PEST INSPECTION

A LOOK INTO PROPERTY INSPECTION: WHAT ACTUALLY QUALIFIES AS PROFESSIONAL

How to choose the right timber decking for your home or project

What to look for in disability services: a practical guide for NDIS participants and their families

Who Should Consider Mole Mapping in Melbourne?

Why Buy Carbohydrate Supplements Are Essential For Weight Gain And Bodybuilding Performance

Engineered Timber Floors Melbourne: Creating Timeless And Durable Interiors

Year 12 Tutoring Helping Students Navigate Their Most Important Academic Year

Simple Home Upgrades That Improve Security, Comfort and Everyday Living

What is a Design and Build Contract? A Complete Guide

How Melbourne Homeowners Keep Their Homes Clean Year-Round (Without Spending Their Weekends Doing It)

Why Choosing The Right GP Bundoora Is Key To Long-Term Health Management

hacklink hack forum hacklink film izle hacklink testsahabetslot gacortipobetRocket Playcasibomiptv satın aliptv satın alcasibomTaraftarium24casibomsahabet 1483jojobetagb99galabetbetofficebetofficedeneme bonusumeritbet girişmeritbetNon Gamstop Sitesroyalbet girişdinamobetholiganbetmarsbahisjojobetjojobetjojobetpokerklas